The Puzzle of TAVR for Bicuspid AS: Still Missing a Piece?

Transcatheter aortic valve replacement (TAVR) was introduced as a therapy reserved for patients with severe, symptomatic and inopearable aortic stenosis (AS) almost 20 years ago. Currently, TAVR is a therapeutic option for patients with severe AS at any degree of estimated surgical risk. TAVR procedures have proliferated as interventional imaging, proceduralists ’ experience and expertise, and requisite TAVR equipment (vascular access sheaths, steering guides, valves, etc) have improved and advanced; multicenter clinical trials have accompanied the investigations seeking to expand TAVR indications, resulting in a robust foundation in procedural success ra tes, description of complications, and tracked outcomes over time.
Source: Journal of Cardiothoracic and Vascular Anesthesia - Category: Anesthesiology Authors: Source Type: research